SPOTLIGHT -
Fremont, CA-The FDA has given the go-ahead to an expansion of Nidek Inc.'s hyperopia study using new software for its U.S. EC-5000 platform.
Endogena Therapeutics receives FDA fast track designation for retinitis pigmentosa treatment
Commercial real estate and your practice, part two with Colin Carr
CLOSE study offers updated surgical classification for treating large full-thickness macular holes
Tips, tricks, what to dos and what not to dos on how you can save money as a healthcare provider on your commercial real estate (Part 1)
Smart contact lens that diagnoses and treats glaucoma
Glaucoma 360: Hypotension and glaucoma progression